Zentalis Pharmaceuticals, Inc. - common stock (ZNTL)
1.7400
+0.0800 (4.82%)
Zentalis Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for the treatment of cancer
The company's expertise lies in its ability to identify and target specific molecular pathways that drive cancer growth and progression. Zentalis is dedicated to advancing a pipeline of small molecules designed to address high unmet medical needs in oncology. Through a combination of scientific rigor and a commitment to patient care, the company aims to deliver effective treatment options that can improve outcomes for individuals battling cancer.
Frequently Asked Questions
Is Zentalis Pharmaceuticals, Inc. - common stock publicly traded?
Yes, Zentalis Pharmaceuticals, Inc. - common stock is publicly traded.
What exchange does Zentalis Pharmaceuticals, Inc. - common stock trade on?
Zentalis Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock?
The ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock is ZNTL on the Nasdaq Stock Market
What is the current price of Zentalis Pharmaceuticals, Inc. - common stock?
The current price of Zentalis Pharmaceuticals, Inc. - common stock is 1.740
When was Zentalis Pharmaceuticals, Inc. - common stock last traded?
The last trade of Zentalis Pharmaceuticals, Inc. - common stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Zentalis Pharmaceuticals, Inc. - common stock?
The market capitalization of Zentalis Pharmaceuticals, Inc. - common stock is 78.39M
How many shares of Zentalis Pharmaceuticals, Inc. - common stock are outstanding?
Zentalis Pharmaceuticals, Inc. - common stock has 45.05M shares outstanding.